Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer’s disease

Journal: Nature Communications

Published: 2019-09-17

DOI: 10.1038/s41467-019-12242-1

Affiliations: 26

Authors: 29

Go to article
Institutions Share
Centre for Eye Research Australia (CERA), Australia 0.13
Department of Surgery, UniMelb, Australia 0.13
Department of Optometry and Vision Sciences, UniMelb, Australia 0.10
Florey Institute of Neuroscience and Mental Health, Australia 0.07
Clinique Ophtalmologique 2121, Canada 0.07
Austin Health, Australia 0.07
Swinburne Centre for Astrophysics and Supercomputing (CAS), Australia 0.05
Alzheimer's Disease Research Unit, McGill University, Canada 0.04
Hôpital Maisonneuve-Rosemont (HMR), Canada 0.03
MoCA Clinic and Institute, Canada 0.03
Optina Diagnostics, Canada 0.03
Murdoch Childrens Research Institute (MCRI), Australia 0.03
Montreal Neurological Institute and Hospital (MNI), McGill University, Canada 0.03
McConnell Brain Imaging Center (BIC), McGill University, Canada 0.03
Swinburne Advanced Visualisation Lab, Australia 0.02
Department of Psychiatry, UniMelb, Australia 0.02
Royal Melbourne Hospital (RMH), Australia 0.02
Translational Neuroimaging Laboratory (TNL), McGill University, Canada 0.02
Douglas Mental Health University Institute, McGill University, Canada 0.02
Department of Electrical Engineering, UdeM, Canada 0.01
Institute of Biomedical Engineering (IGB), UdeM, Canada 0.01
Montreal Heart Institute, UdeM, Canada 0.01
Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia 0.01
Singapore Eye Research Institute (SER), SNEC, Singapore 0.01
PERFORM Centre, Concordia University, Canada 0.01